TNSN04035A1 - Azithromycine en dose unique - Google Patents
Azithromycine en dose uniqueInfo
- Publication number
- TNSN04035A1 TNSN04035A1 TNP2004000035A TNSN04035A TNSN04035A1 TN SN04035 A1 TNSN04035 A1 TN SN04035A1 TN P2004000035 A TNP2004000035 A TN P2004000035A TN SN04035 A TNSN04035 A TN SN04035A TN SN04035 A1 TNSN04035 A1 TN SN04035A1
- Authority
- TN
- Tunisia
- Prior art keywords
- azithromycin
- single dose
- humans
- administering
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
LA PRESENTE INVENTION CONCERNE UNE METHODE DE TRAITEMENT D'INFECTIONS RESPIRATOIRES CHEZ L'HOMME EN ADMINISTRANT UNE DOSE UNIQUE D'AZITHROMYCINE.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31386701P | 2001-08-21 | 2001-08-21 | |
| PCT/IB2002/003076 WO2003018031A2 (fr) | 2001-08-21 | 2002-07-31 | Azithromycine unidose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN04035A1 true TNSN04035A1 (fr) | 2006-06-01 |
Family
ID=23217490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2004000035A TNSN04035A1 (fr) | 2001-08-21 | 2004-02-20 | Azithromycine en dose unique |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20030148964A1 (fr) |
| EP (1) | EP1418924A2 (fr) |
| JP (1) | JP2005501862A (fr) |
| KR (1) | KR20040032942A (fr) |
| AP (1) | AP1729A (fr) |
| BG (1) | BG108537A (fr) |
| BR (1) | BR0211830A (fr) |
| CA (1) | CA2458135A1 (fr) |
| CZ (1) | CZ2004232A3 (fr) |
| EA (1) | EA200400214A1 (fr) |
| EC (1) | ECSP044985A (fr) |
| GE (1) | GEP20063812B (fr) |
| HR (1) | HRP20040163A2 (fr) |
| HU (1) | HUP0401332A2 (fr) |
| IL (1) | IL159585A0 (fr) |
| IS (1) | IS7092A (fr) |
| MA (1) | MA27059A1 (fr) |
| MX (1) | MXPA04001605A (fr) |
| OA (1) | OA12845A (fr) |
| PL (1) | PL367888A1 (fr) |
| SK (1) | SK1012004A3 (fr) |
| TN (1) | TNSN04035A1 (fr) |
| WO (1) | WO2003018031A2 (fr) |
| YU (1) | YU8804A (fr) |
| ZA (1) | ZA200400804B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648473B1 (fr) * | 2003-07-24 | 2009-01-28 | PLIVA HRVATSKA d.o.o. | Dose unique a dissolution rapide d'azithromycine |
| ATE399536T1 (de) | 2003-12-04 | 2008-07-15 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
| CA2547597A1 (fr) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Compositions multiparticulaires a stabilite amelioree |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
| US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| ES2594368T3 (es) | 2005-12-08 | 2016-12-19 | Insmed Incorporated | Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares |
| US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| US20090005326A1 (en) * | 2007-06-26 | 2009-01-01 | Idexx Laboratories, Inc. | Single dose roxithromycin |
| US20090197956A1 (en) * | 2008-02-04 | 2009-08-06 | Arbor Pharmaceuticals, Inc. | Treatment of acute otitis media with xylitol and n-acetylcysteine |
| US20110105421A1 (en) * | 2008-03-14 | 2011-05-05 | The Florida International University Board Of Trustees | Ellagitannins as inhibitors of bacterial quorum sensing |
| EP2717909B1 (fr) | 2011-06-04 | 2017-12-06 | Rochester General Hospital Research Institute | Compositions et procédés associés à la protéine p6 de l'haemophilus influenzae |
| CN104884047A (zh) | 2012-11-29 | 2015-09-02 | 英斯梅德股份有限公司 | 稳定的万古霉素制剂 |
| CA2949078C (fr) * | 2014-05-15 | 2022-09-20 | Insmed Incorporated | Methodes de traitement d'infections pulmonaires mycobacteriennes non-tuberculeuses |
| EP3773505A4 (fr) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | Procédés pour la fabrication continue de produits médicamenteux liposomaux |
| WO2021163451A1 (fr) * | 2020-02-14 | 2021-08-19 | Asklepios Biopharmaceutical, Inc. | Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US53264A (en) * | 1866-03-20 | Improved ditching-machine | ||
| SI7910768A8 (en) | 1979-04-02 | 1996-06-30 | Pliva Pharm & Chem Works | Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives |
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| UA27040C2 (uk) | 1987-07-09 | 2000-02-28 | Пфайзер Інк. | Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу |
| WO1989002271A1 (fr) | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycine et derives utilises comme agents anti-protozoaires |
| YU45590A (sh) | 1990-03-07 | 1992-07-20 | PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. | Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje |
| TW271400B (fr) | 1992-07-30 | 1996-03-01 | Pfizer | |
| DK0699207T3 (da) | 1993-05-19 | 1997-12-08 | Pfizer | Mellemprodukt til azithromycin |
| US5605889A (en) | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
| CN1096862C (zh) | 1994-05-06 | 2002-12-25 | 辉瑞大药厂 | 阿齐霉素的控释剂型 |
| HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
| US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
| US20040053264A1 (en) * | 2002-02-01 | 2004-03-18 | Park Sung Sup | Clinical panel assay using DNA chips |
-
2002
- 2002-07-31 SK SK101-2004A patent/SK1012004A3/sk not_active Application Discontinuation
- 2002-07-31 EA EA200400214A patent/EA200400214A1/ru unknown
- 2002-07-31 KR KR10-2004-7002492A patent/KR20040032942A/ko not_active Application Discontinuation
- 2002-07-31 WO PCT/IB2002/003076 patent/WO2003018031A2/fr not_active Application Discontinuation
- 2002-07-31 JP JP2003522549A patent/JP2005501862A/ja active Pending
- 2002-07-31 EP EP02753170A patent/EP1418924A2/fr not_active Withdrawn
- 2002-07-31 PL PL02367888A patent/PL367888A1/xx not_active Application Discontinuation
- 2002-07-31 YU YU8804A patent/YU8804A/sh unknown
- 2002-07-31 CZ CZ2004232A patent/CZ2004232A3/cs unknown
- 2002-07-31 GE GE5411A patent/GEP20063812B/en unknown
- 2002-07-31 MX MXPA04001605A patent/MXPA04001605A/es active IP Right Grant
- 2002-07-31 OA OA1200400048A patent/OA12845A/en unknown
- 2002-07-31 IL IL15958502A patent/IL159585A0/xx unknown
- 2002-07-31 BR BR0211830-0A patent/BR0211830A/pt not_active IP Right Cessation
- 2002-07-31 CA CA002458135A patent/CA2458135A1/fr not_active Abandoned
- 2002-07-31 AP APAP/P/2004/002968A patent/AP1729A/en active
- 2002-07-31 HU HU0401332A patent/HUP0401332A2/hu unknown
- 2002-08-21 US US10/224,903 patent/US20030148964A1/en not_active Abandoned
-
2003
- 2003-07-25 US US10/628,102 patent/US6987093B2/en not_active Expired - Fee Related
- 2003-12-23 IS IS7092A patent/IS7092A/is unknown
-
2004
- 2004-01-21 BG BG108537A patent/BG108537A/bg unknown
- 2004-01-30 ZA ZA200400804A patent/ZA200400804B/en unknown
- 2004-02-11 MA MA27523A patent/MA27059A1/fr unknown
- 2004-02-19 HR HR20040163A patent/HRP20040163A2/xx not_active Application Discontinuation
- 2004-02-20 EC EC2004004985A patent/ECSP044985A/es unknown
- 2004-02-20 TN TNP2004000035A patent/TNSN04035A1/fr unknown
-
2005
- 2005-06-29 US US11/172,012 patent/US7067493B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20063812B (en) | 2006-05-10 |
| IS7092A (is) | 2003-12-23 |
| HRP20040163A2 (en) | 2005-02-28 |
| MA27059A1 (fr) | 2004-12-20 |
| EA200400214A1 (ru) | 2004-06-24 |
| EP1418924A2 (fr) | 2004-05-19 |
| ECSP044985A (es) | 2004-04-28 |
| US20040023898A1 (en) | 2004-02-05 |
| BG108537A (bg) | 2005-02-28 |
| IL159585A0 (en) | 2004-06-01 |
| US6987093B2 (en) | 2006-01-17 |
| CA2458135A1 (fr) | 2003-03-06 |
| AP2004002968A0 (en) | 2004-03-31 |
| OA12845A (en) | 2006-09-15 |
| US20050250712A1 (en) | 2005-11-10 |
| US20030148964A1 (en) | 2003-08-07 |
| JP2005501862A (ja) | 2005-01-20 |
| WO2003018031A3 (fr) | 2003-10-02 |
| SK1012004A3 (sk) | 2005-04-01 |
| MXPA04001605A (es) | 2004-07-08 |
| HUP0401332A2 (hu) | 2004-11-29 |
| YU8804A (sh) | 2006-08-17 |
| ZA200400804B (en) | 2005-05-03 |
| PL367888A1 (en) | 2005-03-07 |
| BR0211830A (pt) | 2004-09-08 |
| WO2003018031A2 (fr) | 2003-03-06 |
| CZ2004232A3 (cs) | 2005-10-12 |
| AP1729A (en) | 2007-03-26 |
| US7067493B2 (en) | 2006-06-27 |
| KR20040032942A (ko) | 2004-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN04035A1 (fr) | Azithromycine en dose unique | |
| CY1108578T1 (el) | Φαρμακευτικες συνθεσεις (κιτ) περιλαμβανοντας ενωσεις διϋδροπυριδινονης και εναν ανοσορυθμιστικο (ή εναν αντιφλεγμονωδη) παραγοντα και οι χρησεις αυτων | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| BG101118A (en) | Therapeutical compounds | |
| AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
| BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
| ATE343388T1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
| AU2001252958A1 (en) | Compounds and methods to treat alzheimer's disease | |
| BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
| BR0209127A (pt) | compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
| BR0211118A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
| HUP0500039A2 (hu) | Vakcina és eljárás mozgatóneuron-betegségek kezelésére | |
| BR0215395A (pt) | Compostos; processo para a preparação de um composto; composição farmacêutica; e método para o tratamento e/ou profilaxia de doenças que estão relacionadas com o nìvel de glicose no sangue | |
| BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| BR0211635A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer | |
| BR9915729A (pt) | Amidas Èmega de n-arilsulfonil-aminoácido | |
| BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
| TR200101841T2 (tr) | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları | |
| DE69924146D1 (de) | Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen | |
| BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
| EA200400436A1 (ru) | Медикаменты для профилактики и лечения бромидроза | |
| BG100599A (en) | Antiviral form and therapeutical method |